N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

BACKGROUND: Tobacco smoking is a highly prevalent, addictive behaviour and a key public health priority. However available cessation therapies have low quit and high relapse rates, indicating an urgent need for more effective treatments. Predicated on promising preclinical and pilot clinical data, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Arancini, Lauren, Bortolasci, Chiara C., Dodd, Seetal, Dean, Olivia M., Berk, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734392/
https://www.ncbi.nlm.nih.gov/pubmed/31500670
http://dx.doi.org/10.1186/s13063-019-3628-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734392/
https://www.ncbi.nlm.nih.gov/pubmed/31500670
http://dx.doi.org/10.1186/s13063-019-3628-5

Ejemplares similares